Effects of Different Dosing and Feeding Intervals on the Pharmacokinetic Parameters of Herombopag Olamine Tablets
Phase of Trial: Phase I
Latest Information Update: 09 May 2019
Price : $35 *
At a glance
- Drugs Hetrombopag (Primary)
- Indications Idiopathic thrombocytopenic purpura
- Focus Adverse reactions
- Sponsors Jiangsu Hengrui Medicine Co.
- 05 May 2019 Status changed from recruiting to completed.
- 01 Aug 2018 Status changed from not yet recruiting to recruiting.
- 31 Jul 2018 New trial record